Pinz Capital Management’s BioNTech BNTX Stock Holding History

Pinz Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,000	Closed	-$346K	–	134
2020 Q3	$346K	Buy	+5,000	New	+$359K	0.13%	85

Other funds holding BNTX

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Pinz Capital Management's BNTX Position: Q4 2020 in Review

Pinz Capital Management sold out of BioNTech (BNTX) in Q4 2020, closing a stake of 5,000 shares — an estimated $346K sold.

Pinz Capital Management first reported a position in BNTX in Q3 2020 and held it in 1 quarter. The position peaked at $346K in Q3 2020. 194 funds tracked by Wall St. Rank hold BNTX as of Q4 2020.

Pinz Capital Management reported no remaining BioNTech position as of Q4 2020 after selling out during the quarter.
Pinz Capital Management sold 5,000 BioNTech shares in Q4 2020, an estimated $346K.
Pinz Capital Management first reported a position in BioNTech in Q3 2020 and held it in 1 quarter.
Pinz Capital Management's BioNTech position peaked at $346K in Q3 2020.
194 funds tracked by Wall St. Rank held BioNTech as of Q4 2020.

Based on Pinz Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.